📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mef2d potentiates type-2 immune responses and allergic lung inflammation. (2024)

First Author: Szeto ACH

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/science.adl0370

PubMed Identifier: 38935708

Publication URI: http://europepmc.org/abstract/MED/38935708

Type: Journal Article/Review

Volume: 384

Parent Publication: Science (New York, N.Y.)

Issue: 6703

ISSN: 0036-8075